Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
| Record | Firm | Date |
|---|---|---|
| Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL (NCT03245905) | Sun Yat-sen University | 2017-08-20 |
Track Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL) automatically
Every clearance here is in the API, with alerts when new ones post.